Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Allan Siperstein, MD, is Chair of Endocrine Surgery at Cleveland Clinic. He also serves as Program Director for the General Surgery Residency Program and Endocrine Surgery Fellowship.
Dr. Siperstein completed his medical school training at the University of Texas, Southwestern Medical School at Dallas, and his general surgery residency and endocrine surgery training at the University of California, San Francisco. From 1990 until 1999 he was a Faculty member in the Department of General Surgery at the University of California, San Francisco. Since then he has been a Staff member at Cleveland Clinic. In addition to endocrine surgery, he has had a long interest in minimally invasive surgery and surgical sonography. Since 1992, he has been teaching coursework in intraoperative and laparoscopic ultrasound techniques.
Current research interests include thyroid and parathyroid disease, in particular molecular markers for the identification of thyroid cancers. Clinical studies have focused on minimal incision approaches to thyroid and parathyroid surgery. He has had a long interest in the development of technologies for laparoscopic thermal ablation of hepatic tumors. Current studies continue to focus on technical advances in this area, as well as the impact of the procedure on long-term survival. He is a member of many surgical organizations, including the American Surgical Association, the American Association of Endocrine Surgeons and SAGES.
adrenal disease, Adrenal disorders, Advanced Laparoscopic Surgery, Calcium Disorders, endocrine hypertension, endocrine surgery - thyroid and parathyroid diseases and surgery, endocrine surgery (thyroid and parathyroid), general and laparoscopic surgery, General Surgery, laparoscopic radiofrequency ablation of liver tumors, Laparoscopic Solid Organ Surgery, Laparoscopic Surgery, laparoscopic radiofrequency ablation of liver tumors, Laparoscopic Adrenalectomy, Laparoscopic Thermal Ablation Of Liver Tumors, Minimally Invasive Surgery, multiple endocrine neoplasia syndromes, parathyroid and calcium disorders, pancreatic endocrine tumors, thyroid, Thyroid Cancer, thyroid cancers, Thyroid cancers and Flushing Syndromes, Thyroid Disease, thyroid disorders, thyroid nodules
Innovations & Patents
Radiofrequency thermal ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/7/2015, Dr. Siperstein has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.